跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CALCIUM GLUCONATE INJECTION, USP 10% - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CALCIUM GLUCONATE INJECTION, USP 10%
Authorized
STANDARD
CALCIUM GLUCONATE INJECTION, USP 10%
baxter corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
6000aab32bd356ac
Company
baxter corporation
Type
Standard
Approval Details
Approval Id
6000aab32bd356ac
Drug Approval Canada Name
CALCIUM GLUCONATE INJECTION, USP 10%
Product Name
CALCIUM GLUCONATE INJECTION, USP 10%
Status
Marketed
Status Date
2022-06-17
Original Market Date
2022-06-17
Din
02523140
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Ethical
Ahfs
40:12.00
Atc Original
B05XA19 CALCIUM GLUCONATE
Atc Name
b 05 xa 19
Aig Number
0108566002
Company Name
baxter corporation
Company Address
7125 Mississauga Road, Mississauga, Ontario, Canada, L5N 0C2
Active Ingredients
CALCIUM GLUCONATE
100 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
6000aab32bd356ac
Type
Standard
Back to Health Canada Approvals